NXTG.TA
Price:
$77.5
Market Cap:
$62.82M
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-08-12
Stock Exchange
TLV
Ticker
NXTG.TA
According to Nextage Therapeutics Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -7.75. This represents a change of 155.20% compared to the average of -3.04 of the last 4 quarters.
The mean historical PE Ratio of Nextage Therapeutics Ltd over the last ten years is -3.88. The current -7.75 PE Ratio has changed 19.87% with respect to the historical average. Over the past ten years (40 quarters), NXTG.TA's PE Ratio was at its highest in in the December 2019 quarter at 5.11. The PE Ratio was at its lowest in in the June 2021 quarter at -10.98.
Average
-3.88
Median
-3.01
Minimum
-7.58
Maximum
-1.08
Discovering the peaks and valleys of Nextage Therapeutics Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 534.07%
Maximum Annual PE Ratio = -1.08
Minimum Annual Increase = -70.24%
Minimum Annual PE Ratio = -7.58
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.58 | 141.11% |
| 2023 | -3.14 | 4.41% |
| 2022 | -3.01 | -59.52% |
| 2021 | -7.44 | 236.73% |
| 2020 | -2.21 | -70.24% |
| 2019 | -7.43 | 534.07% |
| 2018 | -1.17 | -37.10% |
| 2017 | -1.86 | 72.59% |
The current PE Ratio of Nextage Therapeutics Ltd (NXTG.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-4.58
5-year avg
-4.68
10-year avg
-3.88
Nextage Therapeutics Ltd’s PE Ratio is less than Elbit Imaging Ltd. (-7.10), greater than Endymed Ltd (-8.68), less than Canzon Israel Ltd (-1.24), less than Cannassure Therapeutics Ltd (0), less than Erika B-Cure Laser Ltd (-1.53), less than Almeda Ventures Limited Partnership (-2.10), less than Nextgen Biomed Ltd (-1.11), less than Human Xtensions Ltd. (-0.34), less than Erech Finance Cahalacha Ltd (-0.27), less than ENvizion Medical Ltd. (-0.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| -7.10 | $68.37M | |
| -8.68 | $44.05M | |
| -1.24 | $6.51M | |
| 0 | $22.10M | |
| -1.53 | $17.50M | |
| -2.10 | $28.52M | |
| -1.11 | $5.68M | |
| -0.34 | $7.89M | |
| -0.27 | $6.79M | |
| -0.02 | $139.02M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nextage Therapeutics Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nextage Therapeutics Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nextage Therapeutics Ltd's PE Ratio?
How is the PE Ratio calculated for Nextage Therapeutics Ltd (NXTG.TA)?
What is the highest PE Ratio for Nextage Therapeutics Ltd (NXTG.TA)?
What is the 3-year average PE Ratio for Nextage Therapeutics Ltd (NXTG.TA)?
What is the 5-year average PE Ratio for Nextage Therapeutics Ltd (NXTG.TA)?
How does the current PE Ratio for Nextage Therapeutics Ltd (NXTG.TA) compare to its historical average?